Dry eye / meibomian gland dysfunction
Low-level light therapy for dry eye and meibomian gland dysfunction
Evidence on combined low-level light therapy and intense pulsed light for meibomian gland dysfunction and dry eye outcomes.
Study count
The cited systematic review and meta-analysis analyzed 12 studies of combined LLLT plus IPL.
Evidence grade
low
Panel relevance
not-panel-replicable
Bottom line
Dry-eye content should focus on clinician-delivered periocular devices and eye-safety caveats.
Consensus: Combined LLLT plus IPL appears to improve dry-eye/MGD endpoints, but this is not evidence for red light panels alone.
What the studies found
- LLLT plus IPL reduced Ocular Surface Disease Index scores.
- Tear break-up time and Schirmer test improved at 3 months or less.
- Long-term safety and comparison with alternative treatments need further study.
Dosage and timing
| Wavelengths | Not settled nm |
|---|---|
| Irradiance | Not settled |
| Fluence | Not settled |
| Session time | Ophthalmology/optometry protocol-specific. |
| Frequency | Device-specific. |
| Duration | Benefits reported at <= 3 months, with some sensitivity analysis at >= 6 months. |
| Timing | Clinical treatment schedule-specific. |
| Treatment area | Periocular/meibomian gland area. |
| Device types | Low-level light therapy combined with intense pulsed light. |
| Notes | This is combination therapy, not standalone PBM evidence. |
- No consumer panel protocol.
- Eye protection and clinician oversight are mandatory.
- Separate LLLT plus IPL evidence from standalone red/NIR light claims.
Caveats
- Dry eye can have multiple causes and needs eye-care evaluation.
- Do not suggest shining panels at the eyes.
Cited peer-reviewed sources
Chan KE, Lau BSR, Lim BXH, et al. Contact Lens & Anterior Eye. 2025.
A meta-analysis found combined LLLT plus intense pulsed light improved dry-eye and meibomian gland dysfunction endpoints.
Last reviewed: 2026-06-15